drugset / Trial / NCT01022983

Preoperative Levosimendan and Heart Failure

NCT01022983

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the safety and efficacy of Levosimendan given preoperative to patients with heart failure undergoing noncardiac surgery.

Timeline

Start
2011-04
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levosimendan Other / unclassified 0.1 ug/kg

Indications